CD46

CD46

CD46 詳細

Molecule Name
Membrane cofactor protein
分子の別称
CD46,AHUS2,MCP,MIC10,TLX,TRA2.10
Drug Development Progress
治験薬の数5
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
TLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
バックグランド
Complement regulatory protein CD46 is also known as membrane Cofactor Protein (MCP), is a type I membrane protein and is a regulatory part of the complement system. CD46 is expressed by all cells except erythrocytes. MCP acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue, and also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. In T-cells by binding to CD46, A number of viral and bacterial pathogens seem to exploit this property and directly induce an immunosuppressive phenotype. Defects in CD46 are a cause of susceptibility to hemolytic uremic syndrome atypical type 2 (AHUS2).

CD46 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Anti-CD46 antibody drug conjugate (Fortis Therapeutics)FG-3246; FOR-46Phase 2 ClinicalUniversity Of California San Diego
Multiple Myeloma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
詳細
EnadenotucirevColoAd-1; Oncolytic Ad11/Ad3Phase 1 ClinicalAkamis Bio Ltd
Carcinoma, Non-Small-Cell Lung; Colonic Neoplasms; Colorectal Neoplasms; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms
詳細
AugmAbBRM-132Phase 1 ClinicalCompliment Corp
Lymphoma, Non-Hodgkin; Neoplasms
詳細
YS-5YS-5Phase 1 ClinicalFortis Therapeutics Inc, United States Department Of Defense
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
詳細
FG-318089Zr-DFO-YS-5; 89Zr-DFO-YS5Phase 1 ClinicalFortis Therapeutics Inc
Multiple Myeloma; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
詳細